____________________________________________________________________________________________________

An Evidence-Based Approach to Address Infant Malnutrition & Failure to Thrive
Presented by: Nutricia North America
Date/time: Tuesday, December 14, 10:00 AM - 12:00 PM ET
This virtual event will be accessible from within the Annual Meeting agenda

Objectives:

• Learn how to identify infants with growth failure and compare to most recent research
• Compare US and European current practices of nutritional management of infants with FTT
• Review the role of energy and nutrient dense formulas in managing infants with malnutrition based on current evidence.
• Assess current research on how to transition infants to energy dense formulas based on tolerance

Speakers:
    Dr. Rosan Meyer
    Paediatric Research Dietitian
    Honorary Senior Lecturer
    Imperial College, London

    Nishant Patel, MD
    Pediatric Gastroenterologist
    Arnold Palmer Hospital – Center for Digestive Health and Nutrition

____________________________________________________________________________________________________

Expert Perspectives on Improving Early Recognition of Eosinophilic Esophagitis and Examining the Potential Clinical Utility of Emerging Targeted Therapy

This educational symposium is accredited by the Medical Learning Institute, Inc.
This activity is developed with our educational partner, PVI, PeerView Institute for Medical Education.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

Date/time: Tuesday, December 14, 10:00 AM – 11:30 AM ET
Register here: PeerView.com/2021EoENashville-Virtual

Objectives:
Upon completion of this accredited CE activity, participants should be better able to:

• Distinguish signs and symptoms of eosinophilic esophagitis (EoE) among children and adults to enable an earlier diagnosis and minimize complications due to uncontrolled disease
• Summarize underlying mechanisms of EoE, including the role of key cytokines such as interleukin-4, -13, and -5 as drivers of type 2 inflammation and how this relates to potential treatment
• Review the limitations of the current standard of care for the treatment of EoE
• Apply the latest expert recommendations and clinical evidence to the treatment of patients with EoE, particularly as novel and emerging agents become available

Speakers:
Chair & Presenter
Chris A. Liacouras, MD
The Children's Hospital of Philadelphia
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Presenter
Amal H. Assa'ad, MD
University of Cincinnati
Cincinnati Children’s Hospital
Cincinnati, Ohio

Presenter
Kathryn A. Peterson, MD, MSCI
University of Utah
Salt Lake City, Utah

Agenda

• Opening Monologue: Let’s Talk Candidly About Eosinophilic Esophagitis
• Meet the Experts: What Is the Importance of Early Diagnosis of EoE?
• Challenge the Experts: How Will Emerging Targeted Therapies Change the Management of EoE?
• Closing Monologue: Remember This as You Return to Your Practices and Patients
• Audience Q&A
• Adjourn

____________________________________________________________________________________________________

When is IBS more than “just” IBS?
Sorting through common causes of functional diarrhea in clinical practice

Provided by: Gi Health Foundation
Accredited by: Rehoboth McKinley Christian Health Care Services
Supported by an education grant from QOL Medical, LLC.

Date: Wednesday, December 15, 2021
Time: 12:00 – 1:30 PM ET
This virtual event will be accessible from within the Annual Meeting agenda 

Target Audience:

This activity has been designed to meet the educational needs of pediatric gastroenterologists and other healthcare providers involved in the care of patients with irritable bowel syndrome (IBS).

Educational Objectives:

• Recognize the symptoms of carbohydrate malabsorption across the age spectrum.
• Incorporate current diagnostic strategies into clinical practice to differentiate among the various carbohydrate malabsorption disorders.
• Compare and contrast the clinical presentation, diagnosis, and management of carbohydrate malabsorption from other causes of functional GI symptoms seen in pediatric clinical practice, particularly in patients with suspected IBS.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Gi Health Foundation (GiHF). RMCHCS is accredited by the NMMS to provide continuing medical education for physicians. RMCHCS designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty:

Carlo Di Lorenzo, MD, (Program Chair)
Professor of Pediatrics
The Ohio State University College of Medicine
Chief, Division of Gastroenterology, Hepatology and Nutrition
Nationwide Children’s Hospital
Columbus, Ohio

Tanaz Farzan Danialifar, MD
Children’s Hospital Los Angeles
Los Angeles, California

Miguel Saps, MD
University of Miami, Miller School of Medicine
Miami, Florida

Samuel Nurko, MD, MPH
Boston Children’s Hospital
Boston, MA

Agenda:
Times shown in ET

12:00 PM | Introduction/Best Abstracts of Disorders of Gut-Brain Interaction
                Carlo Di Lorenzo, MD

12:15 PM | Is It the Carbs?
             Tanaz Farzan Danialifar, MD

12:35 PM | What You Can Find if You Look Into the Gut: Actionable Etiologies
                Samuel Nurko, MD, MPH

12:55 PM | When IBS is “IBS Plus”
                Miguel Saps, MD

1:15 PM | Q&A/Panel Discussion

1:30 PM | Adjourn

____________________________________________________________________________________________________

Building new treatment paradigms in the management of pediatric cholestasis
Presented by: Mirum Pharmaceuticals
Date/Tim: Thursday, December 16, 8:00 PM - 9:30 PM ET
This virtual presentation will be accessible from the Annual Meeting agenda.

Program
8:00–8:15 Chair’s welcome and introduction
                     Tamir Miloh, MD, Miami Transplant Institute, USA
8:15–8:40 Constructing a new approach in the management of Alagille syndrome
                     Noelle Ebel, MD, Stanford University, USA 
8:40–9:00 Establishing new foundations for children with progressive familial intrahepatic cholestasis
                    Ryan Himes, MD, Ochsner Hospital for Children, USA 
9:00–9:10 Structuring new outcomes for biliary atresia
                      Tamir Miloh 
9:10–9:25 Panel discussion All 
9:25–9:30 Chair’s close
                     Tamir Miloh